Elevation Oncology Inc. (ELEV)
NASDAQ: ELEV
· Real-Time Price · USD
0.38
0.06 (18.79%)
At close: Jun 09, 2025, 3:59 PM
Elevation Oncology Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.99M | -44.48M | -41.95M | -39.7M | -39.35M | -45.7M | -56.85M | -85.05M | -94.86M | -95.08M | -85.66M | -59.09M | -44.22M | -32.04M | -31.31M | -22.05M | -20.4M |
Depreciation & Amortization | -234K | 24K | 29K | 33K | 39K | 39K | 39K | 38K | 33K | 27K | 22K | 17K | 18K | 18K | 28K | 25K | 19K |
Stock-Based Compensation | 4.37M | 4.28M | 3.39M | 3.08M | 2.77M | 3.33M | 3.91M | 3.95M | 4.04M | 3.21M | 3.04M | 2.81M | 2.13M | 1.57M | 898K | 254K | 108K |
Other Working Capital | 4.32M | 3.79M | 1.25M | -2.09M | -9.43M | -6.58M | -5.8M | -14.52M | 527K | 5.58M | 5.74M | 15.37M | 7.13M | 313K | 969K | 1.35M | 86K |
Other Non-Cash Items | 299K | 2.12M | 5.53M | 6.04M | 5.31M | 3.5M | 354K | 248K | 73K | 74K | 367K | -3.79M | -3.63M | 1.44M | 6.19M | 9.21M | 10.11M |
Deferred Income Tax | n/a | n/a | -3.44M | -3.64M | -3.66M | -3.66M | -226K | -22K | n/a | n/a | -283K | -283K | -283K | -283K | n/a | n/a | n/a |
Change in Working Capital | 4.44M | 3.84M | 236K | -6.99M | -13.04M | -13.69M | -9.08M | -11.84M | 2.42M | 6.29M | 5.97M | 15.98M | 7.34M | 283K | 5.75M | 313K | 89K |
Operating Cash Flow | -39.5M | -36.36M | -38.34M | -43.32M | -48.92M | -56.18M | -61.85M | -92.67M | -88.29M | -85.48M | -76.55M | -40.27M | -34.71M | -30.17M | -24.64M | -21.46M | -20.18M |
Capital Expenditures | n/a | n/a | n/a | 8.21M | n/a | n/a | -86K | -172K | -172K | -172K | -86K | n/a | n/a | n/a | -71K | -71K | -71K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 86K | 86K | 86K | 86K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -69.56M | -69.56M | -63.47M | -89.62M | -42.66M | -42.66M | -53.54M | -27.07M | -33.04M | -112.31M | -98.49M | -85.25M | -79.27M | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 64.26M | 61.2M | 50.2M | 41.1M | 48.3M | 54.2M | 69.7M | 94.8M | 94.6M | 68M | 43M | 16.3M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -29.45M | -29.43M | -29.43M | -37.67M | 5.64K | 11.54K | 90.98K | 43.1K | 36.93K | -79.26M | -79.35M | -79.26M | -79.27M | n/a | n/a | n/a | n/a |
Investing Cash Flow | -5.31M | -8.37M | -13.27M | -48.52M | 5.64M | 11.54M | 16.16M | 67.65M | 61.47M | -44.4M | -55.58M | -68.94M | -79.27M | n/a | -71K | -71K | -71K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -39K | -48K | -46K | -47K | -38K | -24K | -26K | -29K | -47K | -35K | -31K | -25K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 159K | 779K | 779K | 797K | 1.89M | 1.5M | 1.5M | 31M | 29.76M | 29.55M | -62.43M | -91.96M | 19K | -11K | 91.79M | 91.79M | -185K |
Financial Cash Flow | 14.67M | 44.94M | 44.94M | 44.96M | 78.01M | 47.98M | 47.97M | 77.47M | 29.71M | 29.51M | 29.52M | 5.08M | 97.08M | 97.05M | 161.88M | 156.81M | 64.83M |
Net Cash Flow | -30.14M | 209K | -6.68M | -46.88M | 34.73M | 3.34M | 2.29M | 52.44M | 2.89M | -100.37M | -102.61M | -104.14M | -16.9M | 66.88M | 137.17M | 135.28M | 44.58M |
Free Cash Flow | -31.3M | -28.16M | -30.14M | -35.11M | -48.92M | -56.18M | -61.93M | -92.85M | -88.46M | -85.66M | -76.63M | -40.27M | -34.71M | -30.17M | -24.71M | -21.53M | -20.25M |